Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yingqiu Ma

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Biometrical Journal. Biometrische Zeitschrift|February 8, 2013
Individualized two-stage multiple testing procedures with corresponding interval estimatesArthur Cohen, Yingqiu Ma, Harold B Sackrowitz
Pharmaceutical Statistics|January 23, 2015
Adaptive and repeated cumulative meta-analyses of safety data during a new drug development processHui Quan, Yingqiu Ma, Yan Zheng, et al.
ACS Omega|November 25, 2024
Multi-omics Insights into PDHA1 as a Predictive Biomarker for Prognosis, Immunotherapy Efficacy, and Drug Sensitivity in Hepatocellular CarcinomaYong Pan, Yiru Zhang, Daiwen Mao, et al.
Gene|April 5, 2025
LncRNA SNHG1: A novel biomarker and therapeutic target in hepatocellular carcinomaZhou Fang, Yong Pan, Zhengmei Lu, et al.
International Journal of Nanomedicine|July 14, 2026
Targeted Delivery of Schisandrin A to Cardiac Endothelium Alleviates Myocardial Ischemia-Reperfusion Injury via Suppression of FerroptosisXue Guan, Xiaolei Li, Jing Yang, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Biometrical Journal. Biometrische Zeitschrift|February 8, 2013
Individualized two-stage multiple testing procedures with corresponding interval estimatesArthur Cohen, Yingqiu Ma, Harold B Sackrowitz
Pharmaceutical Statistics|January 23, 2015
Adaptive and repeated cumulative meta-analyses of safety data during a new drug development processHui Quan, Yingqiu Ma, Yan Zheng, et al.
ACS Omega|November 25, 2024
Multi-omics Insights into PDHA1 as a Predictive Biomarker for Prognosis, Immunotherapy Efficacy, and Drug Sensitivity in Hepatocellular CarcinomaYong Pan, Yiru Zhang, Daiwen Mao, et al.
Gene|April 5, 2025
LncRNA SNHG1: A novel biomarker and therapeutic target in hepatocellular carcinomaZhou Fang, Yong Pan, Zhengmei Lu, et al.
International Journal of Nanomedicine|July 14, 2026
Targeted Delivery of Schisandrin A to Cardiac Endothelium Alleviates Myocardial Ischemia-Reperfusion Injury via Suppression of FerroptosisXue Guan, Xiaolei Li, Jing Yang, et al.
Pageof 1